BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30314951)

  • 1. Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis.
    Archibugi L; Arcidiacono PG; Capurso G
    Dig Liver Dis; 2019 Jan; 51(1):28-37. PubMed ID: 30314951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use and risk of pancreatic cancer: a meta-analysis.
    Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
    Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis.
    Tamburrino D; Crippa S; Partelli S; Archibugi L; Arcidiacono PG; Falconi M; Capurso G
    Dig Liver Dis; 2020 Apr; 52(4):392-399. PubMed ID: 32113888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2006 Oct; 24(30):4808-17. PubMed ID: 17001070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies.
    Zhang Y; Liang M; Sun C; Qu G; Shi T; Min M; Wu Y; Sun Y
    Pancreas; 2019 Feb; 48(2):142-150. PubMed ID: 30640225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies.
    Bonovas S; Filioussi K; Sitaras NM
    Am J Gastroenterol; 2008 Oct; 103(10):2646-51. PubMed ID: 18684187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.
    Bonovas S; Filioussi K; Flordellis CS; Sitaras NM
    J Clin Oncol; 2007 Aug; 25(23):3462-8. PubMed ID: 17687150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
    Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
    Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies.
    Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Deng Y; Peng Q; Li S; Qin X
    Cancer Causes Control; 2014 Feb; 25(2):237-49. PubMed ID: 24265089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.
    Lytras T; Nikolopoulos G; Bonovas S
    World J Gastroenterol; 2014 Feb; 20(7):1858-70. PubMed ID: 24587664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and risk of breast cancer: a meta-analysis of observational studies.
    Undela K; Srikanth V; Bansal D
    Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and risk of bladder cancer: a meta-analysis.
    Zhang XL; Geng J; Zhang XP; Peng B; Che JP; Yan Y; Wang GC; Xia SQ; Wu Y; Zheng JH
    Cancer Causes Control; 2013 Apr; 24(4):769-76. PubMed ID: 23361339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.
    Bonovas S; Filioussi K; Sitaras NM
    Int J Cancer; 2008 Aug; 123(4):899-904. PubMed ID: 18491405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials.
    Zhang XL; Liu M; Qian J; Zheng JH; Zhang XP; Guo CC; Geng J; Peng B; Che JP; Wu Y
    Br J Clin Pharmacol; 2014 Mar; 77(3):458-65. PubMed ID: 23879311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.
    Yi X; Jia W; Jin Y; Zhen S
    PLoS One; 2014; 9(1):e87019. PubMed ID: 24498014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study.
    Archibugi L; Piciucchi M; Stigliano S; Valente R; Zerboni G; Barucca V; Milella M; Maisonneuve P; Delle Fave G; Capurso G
    Sci Rep; 2017 Oct; 7(1):13024. PubMed ID: 29026148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and risk of prostate cancer: a meta-analysis of observational studies.
    Bansal D; Undela K; D'Cruz S; Schifano F
    PLoS One; 2012; 7(10):e46691. PubMed ID: 23049713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.
    Walker EJ; Ko AH; Holly EA; Bracci PM
    Cancer; 2015 Apr; 121(8):1287-94. PubMed ID: 25649483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.